Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4405 ARTÍCULOS , VIENDO DEL 481 AL 495

Effects of Safinamide on Pain in Fluctuating Parkinson's Disease Patients: A Post-Hoc Analysis

Cattaneo C, Barone P, Bonizzoni E, Sardina M.

J Parkinsons Dis. 2017;7(1):95-101. doi: 10.3233/JPD-160911.

The Proteasome Inhibition Model of Parkinson's Disease

Bentea E, Verbruggen L, Massie A.

J Parkinsons Dis. 2017;7(1):31-63. doi: 10.3233/JPD-160921.

Sexual Preoccupation Behavior in Parkinson's Disease

Bronner G, Hassin-Baer S, Gurevich T.

J Parkinsons Dis. 2017;7(1):175-182. doi: 10.3233/JPD-160926.

Osteopathic manipulation as a complementary approach to Parkinson's disease: A controlled pilot study

DiFrancisco-Donoghue J, Apoznanski T, de Vries K, Jung MK, Mancini J, Yao S.

NeuroRehabilitation. 2017;40(1):145-151. doi: 10.3233/NRE-161400.

Interventions in Parkinson's disease: Role of executive function

Mahajan A, Deal JA, Carlson M.

Front Biosci (Landmark Ed). 2017 Jan 1;22(3):416-427. doi: 10.2741/4492.

Mitochondria in the pathophysiology of Alzheimer's and Parkinson's diseases

Onyango IG, Khan SM, Bennett JP Jr.

Front Biosci (Landmark Ed). 2017 Jan 1;22(5):854-872. doi: 10.2741/4521.

Caffeine; the Forgotten Potential for Parkinson's Disease

Negida A, Elfil M, Attia, Farahat E, Gabr M, Essam A, Attia D, Ahmed H.

CNS Neurol Disord Drug Targets. 2017;16(6):652-657. doi: 10.2174/1871527315666161107091149.

Meta-Analysis of Creatine for Neuroprotection Against Parkinson's Disease

Attia, Ahmed H, Gadelkarim M, Morsi M, Awad K, Elnenny M, Ghanem E, El-Jaafary S, Negida A.

CNS Neurol Disord Drug Targets. 2017;16(2):169-175. doi: 10.2174/1871527315666161104161855.

Transcranial Magnetic Stimulation for the Assessment of Neurodegenerative Disease

Vucic S, Kiernan MC.

Neurotherapeutics. 2017 Jan;14(1):91-106. doi: 10.1007/s13311-016-0487-6.

Recent Highlights on Molecular Hybrids Potentially Useful in Central Nervous System Disorders

Matias M, Silvestre S, Falcao A, Alves G.

Mini Rev Med Chem. 2017;17(6):486-517. doi: 10.2174/1389557517666161111110121.

Mesenchymal Stem Cells as a Source of Dopaminergic Neurons: A Potential Cell Based Therapy for Parkinson's Disease

Venkatesh K, Sen D.

Curr Stem Cell Res Ther. 2017;12(4):326-347. doi: 10.2174/1574888X12666161114122059.

Instability Resistance Training Improves Neuromuscular Outcome in Parkinson's Disease

Silva-Batista C, Corcos DM, Barroso R, David FJ, Kanegusuku H, Forjaz C, DE Mello MT, Roschel H, Tricoli V, Ugrinowitsch C.

Med Sci Sports Exerc. 2017 Apr;49(4):652-660. doi: 10.1249/MSS.0000000000001159.

Regular Exercise, Quality of Life, and Mobility in Parkinson's Disease: A Longitudinal Analysis of National Parkinson Foundation Quality Improvement Initiative Data

Rafferty MR, Schmidt PN, Luo ST, Li K, Marras C, Davis TL, Guttman M, Cubillos F, Simuni T; all NPF-QII Investigators.

J Parkinsons Dis. 2017;7(1):193-202. doi: 10.3233/JPD-160912.

Genetics meets pathology - an increasingly important relationship

Bonthron DT, Foulkes WD.

J Pathol. 2017 Jan;241(2):119-122. doi: 10.1002/path.4849.

[Multiple eccrine hidrocystomas on the lower forehead and nose of a 60-year-old man]

Winkler JK, Hartschuh W, Enk A, Toberer F.

Hautarzt. 2017 May;68(5):393-395. doi: 10.1007/s00105-016-3900-5.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias